Build Drug Candidates in Weeks

The AlphaFold Revolution and Beyond

Generative AI for molecular design uses deep learning to propose novel molecular structures with desired properties, drug-likeness, target binding affinity, selectivity, synthesizability, and ADMET properties (absorption, distribution, metabolism, excretion, and toxicity). Models like graph neural networks, variational autoencoders, and diffusion models generate molecular candidates that human medicinal chemists would be unlikely to conceive, dramatically expanding the explorable chemical space.

AI-driven target identification and validation uses multimodal data, genomics, proteomics, transcriptomics, and clinical data, to identify novel disease targets and validate their therapeutic relevance before committing to expensive drug development programs. Knowledge graphs connect molecular interactions, disease associations, genetic evidence, and clinical outcomes to surface high-confidence target hypotheses that prioritize drug discovery investment.

Click to enlarge